Peptic ulcer disease is the presence of ulceration in the stomach and proximal duodenum commonly and in the lower esophagus, distal duodenum or jejunum infrequently. It is characterized by mucosal damage secondary to pepsin and gastric acid secretion.
It is the principal cause of upper gastrointestinal hemorrhage.
Appropriate therapy depends on the cause of peptic ulcer disease.
New drug applications approved by US FDA as of 1 - 15 July 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Vonoprazan is as effective as the proton pump inhibitor (PPI) lansoprazole for preventing peptic ulcer recurrence in patients receiving low-dose aspirin (LDA) therapy for cardiovascular or cerebrovascular protection, as shown in a phase III study. In addition, the drug appears to be well tolerated, with its preventive effect enduring with long-term use.
Helicobacter pylori (H. pylori) infection is associated with conditions such as gastritis, peptic ulcer, gastric cancer, and certain types of lymphoma. A common presenting complaint among all these H. pylori-related illnesses is dyspepsia. Dr Desmond Wai from the Desmond Wai Liver and Gastrointestinal Diseases Centre, Mount Elizabeth Novena Specialist Centre, Singapore, speaks on the important role general practitioners (GPs) play in recognizing, diagnosing, and treating H. pylori.
Rebamipide reduces atypical gastrointestinal (GI) symptoms, including gastroesophageal reflux, gastroparesis, peptic ulcer, and constipation, in patients with type 2 diabetes mellitus (T2DM), according to an investigator-initiated clinical trial.
Switching from the generic omeprazole to the newer, optically pure S-isoform of omeprazole, sold as esomeprazole, offers little or no advantage in controlling stomach pH and treating peptic ulcers, according to a comparative analysis.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Gastroenterology - Malaysia digital copy today!
A new technology involving the use of monocyte-derived hepatocyte-like (MH) cells has demonstrated high sensitivity and specificity in the diagnosis of idiosyncratic drug-induced liver injury (DILI), data presented at the Asian Pacific Digestive Week (APDW) 2017 held in Hong Kong have shown.